Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

BioSenic puts Phase IIb ALLOB trial on hold

Date
Mon, 06/19/2023 - 12:00
Year
2023
Filter Criteria
Press Releases
Document Upload
BIOS_PR_2023-06-19_ALLOB PhII results_EN_Final-1.pdf216.15 KB
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions